ArticleAmerican journal of obstetrics and gynecology2011
Midpregnancy levels of angiogenic markers in relation to maternal characteristics.
Article in American journal of obstetrics and gynecology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 40 citations in OpenAlex.
- Article
- The effect of nicotine-containing products and fetal sex on placenta-associated circulating midpregnancy biomarkers.Biology of sex differences · 2022Article
- Performance of sFlt-1/PIGF Ratio for the Prediction of Perinatal Outcome in Obese Pre-Eclamptic Women.Journal of clinical medicine · 2022Article
- Maternal risk of hypertension 7-15 years after pregnancy: clues from the placenta.BJOG : an international journal of obstetrics and gynaecology · 2021Article
- Lead exposure and association with angiogenic factors and hypertensive disorders of pregnancy.Pregnancy hypertension · 2020Article
- Associations between First Trimester Maternal Nutritional Score, Early Markers of Placental Function, and Pregnancy Outcome.Nutrients · 2020Article
- No association between early antiretroviral therapy during pregnancy and plasma levels of angiogenic factors: a cohort study.BMC pregnancy and childbirth · 2019Article
- A Review of Angiogenic Imbalance in HIV-Infected Hypertensive Disorders of Pregnancy.Current hypertension reports · 2019Review
- Circulating soluble fms-like tyrosine kinase-1, soluble endoglin and placental growth factor during pregnancy in normotensive women in KwaZulu-Natal, South Africa.African health sciences · 2019Article
- Impact of obesity on angiogenic and inflammatory markers in the Finnish Genetics of Pre-eclampsia Consortium (FINNPEC) cohort.International journal of obesity (2005) · 2019Article
- What are the metabolic precursors which increase the risk of pre-eclampsia and how could these be investigated further.Placenta · 2017Review
- Early Prognostic Factors for the Progress of Preeclampsia - Our Experience in the Period 2010-2011.Open access Macedonian journal of medical sciences · 2016Article
- Racial-ethnic differences in midtrimester maternal serum levels of angiogenic and antiangiogenic factors.American journal of obstetrics and gynecology · 2016Article
- Epidemiology of preeclampsia: impact of obesity.Nutrition reviews · 2013Review
- New developments in the pathogenesis of preeclampsia.Advances in chronic kidney disease · 2013Review
- Gestation dependant changes in angiogenic factors and their associations with fetal growth measures in normotensive pregnancy.PloS one · 2013Article
- Mid-pregnancy levels of angiogenic markers as indicators of pathways to preterm delivery.The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians · 2012Article
- Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia.The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians · 2011Article
- Maternal angiogenic profile in pregnancies that remain normotensive.European journal of obstetrics, gynecology, and reproductive biology · 2011Article
Corrections and comments
- Erratum issued
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
Abstract
objectiveThe purpose of this study was to describe relations among maternal demographic and lifestyle characteristics and midpregnancy levels of angiogenic markers (soluble Fms-like tyrosine kinase-1, placental growth factor, soluble endoglin). STUDY
designIn a large pregnancy cohort, linear models were used to evaluate relations among maternal characteristics and midpregnancy angiogenic markers with and without covariate adjustment. Associations were examined in a subcohort that included term and preterm deliveries (n = 1302) and among "normal" term pregnancies (n = 668).
resultsConcentrations of all factors declined with increasing maternal body mass index. Multiparous women had lower soluble Fms-like tyrosine kinase-1 levels than primiparous women. Higher placental growth factor and slightly lower soluble endoglin levels were observed among women who smoked at enrollment, but not among those women who quit before enrollment. African American women had higher levels of all markers.
conclusionUnderstanding relations among maternal characteristics and levels of angiogenic factors may improve studies that use these markers to examine etiology and/or to predict adverse pregnancy outcome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.